Geode Capital Management, LLC Day One Biopharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,462,982 shares of DAWN stock, worth $18.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,462,982

Previous 1,432,697 2.11%

Holding current value

$18.2 Million

Previous $20 Million 7.13%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$12.46 - $16.39 $377,351 - $496,371	30,285 Added 2.11%	1,462,982 $18.5 Million
Q3 2024 Nov 12, 2024	BUY	$12.72 - $16.03 $1.74 Million - $2.19 Million	136,458 Added 10.53%	1,432,697 $20 Million
Q2 2024 Aug 09, 2024	SELL	$12.03 - $17.69 $971,085 - $1.43 Million	-80,722 Reduced 5.86%	1,296,239 $17.9 Million
Q1 2024 May 13, 2024	BUY	$13.56 - $17.46 $381,605 - $491,359	28,142 Added 2.09%	1,376,961 $22.7 Million
Q4 2023 Feb 13, 2024	BUY	$9.68 - $15.37 $539,224 - $856,185	55,705 Added 4.31%	1,348,819 $19.7 Million
Q3 2023 Nov 13, 2023	BUY	$11.22 - $14.86 $4.13 Million - $5.47 Million	367,898 Added 39.76%	1,293,114 $15.9 Million
Q2 2023 Aug 11, 2023	BUY	$11.74 - $14.47 $3.95 Million - $4.87 Million	336,740 Added 57.22%	925,216 $11 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $101,898 - $187,092	7,992 Added 1.38%	588,476 $7.87 Million
Q4 2022 Feb 13, 2023	BUY	$18.77 - $22.0 $485,279 - $568,788	25,854 Added 4.66%	580,484 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $1.85 Million - $2.98 Million	112,271 Added 25.38%	554,630 $11.1 Million
Q2 2022 Aug 12, 2022	BUY	$5.72 - $17.9 $684,478 - $2.14 Million	119,664 Added 37.08%	442,359 $7.92 Million
Q1 2022 May 13, 2022	BUY	$9.12 - $17.47 $1.03 Million - $1.98 Million	113,352 Added 54.15%	322,695 $3.2 Million
Q4 2021 Feb 11, 2022	BUY	$15.65 - $26.33 $355,505 - $598,112	22,716 Added 12.17%	209,343 $3.53 Million
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.92 $3.03 Million - $4.24 Million	151,692 Added 434.21%	186,627 $4.43 Million
Q2 2021 Aug 13, 2021	BUY	$19.0 - $23.69 $663,765 - $827,610	34,935 New	34,935 $795,000

Others Institutions Holding DAWN

# of Institutions

176

Shares Held

77.8M

Call Options Held

139K

Put Options Held

253K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $913M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Day One Biopharmaceuticals, Inc. Transaction History